1-chloro-10-iododecane | CAS:57152-87-1

We serve 1-chloro-10-iododecane CAS:57152-87-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-chloro-10-iododecane

Chemical Name:1-chloro-10-iododecane
CAS.NO:57152-87-1
Synonyms:1-chloro-10-iododecane
1-Chlor-10-jod-decan
Decane,1-chloro-10-iodo
1-chloro-10-iodo-decane
1-Chlor-10-iod-decan
Molecular Formula:C10H20ClI
Molecular Weight:302.62300
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:The substance is unstable and should be kept away from light and refrigerated
Application:Organic synthesis intermediate



Contact us for information like 1-chloro-10-iododecane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Chlor-10-iod-decan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Chlor-10-jod-decan Use and application,1-chloro-10-iodo-decane technical grade,usp/ep/jp grade.


Related News: Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.1-tert-butyl-4-(chloromethyl)benzene manufacturer Large pharmaceutical companies are investing a disproportionately large amount of annual revenue in research and development (R&D), according to GlobalData’s Company Financials database.2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol supplier However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine vendor However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).